Mather Group’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$28.1K Buy
45
+15
+50% +$8.79K ﹤0.01% 1343
2026
Q2
$15.9K Hold
30
– – ﹤0.01% 1387
2026
Q1
$14.4K Buy
+30
New +$15.4K ﹤0.01% 1361
2025
Q4
– Sell
-43
Closed -$22.1K – 1255
2025
Q3
$22.1K Buy
+43
New +$18.8K ﹤0.01% 1098
2025
Q2
– Sell
-46
Closed -$14K – 1283
2025
Q1
$14K Buy
46
+16
+53% +$5.38K ﹤0.01% 1176
2024
Q4
$10K Hold
30
– – ﹤0.01% 1249
2024
Q3
$10K Sell
30
-18
-38% -$6.84K ﹤0.01% 1183
2024
Q2
$19.4K Sell
48
-21
-30% -$8.32K ﹤0.01% 1269
2024
Q1
$21.2K Buy
+69
New +$24.3K ﹤0.01% 1050

Other funds holding MEDP

Mather Group's MEDP Position: Q3 2026 in Review

Mather Group increased its Medpace (MEDP) stake by 50% in Q3 2026, buying an estimated $8.79K and bringing the position to 45 shares worth $28.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1343.

Mather Group first reported a position in MEDP in Q1 2024 and has held it in 9 quarters since. 135 funds tracked by Wall St. Rank hold MEDP as of Q3 2026.

  • Mather Group held 45 shares of Medpace worth $28.1K as of Q3 2026.
  • Mather Group bought 15 Medpace shares in Q3 2026, an estimated $8.79K.
  • Medpace made up ﹤0.01% of Mather Group's portfolio in Q3 2026, its #1343 holding.
  • Mather Group first reported a position in Medpace in Q1 2024 and has held it in 9 quarters since.
  • 135 funds tracked by Wall St. Rank held Medpace as of Q3 2026.

Based on Mather Group's 13F filing for Q3 2026, filed 14 Oct 2026.